Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Rainier Acquisition CorpRNAQ · Entity 527 | Director · Chief Executive Officer | August 26, 2026 | August 26, 2026 |
| Tessera Defense & Homeland Security Inc.PHGE · Entity 8384 | Director | March 29, 2022 | March 31, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Rainier Acquisition Corp
Report date August 26, 2026 · Filed August 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B ordinary sharesSEC Table II · derivative / convertible security | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-08-26 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: Each Class B ordinary share is convertible into one Class A ordinary share at the option of the holder, and will automatically convert at the time of the Issuer's initial business combination or earlier at the option of the holder, on a one-for-one basis. The Class B ordinary shares have no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Class B ordinary share is convertible into one Class A ordinary share at the option of the holder, and will automatically convert at the time of the Issuer's initial business combination or earlier at the option of the holder, on a one-for-one basis. The Class B ordinary shares have no expiration date.
Tessera Defense & Homeland Security Inc.
Report date March 29, 2022 · Filed March 31, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock Options - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $1.41 · Expires 2032-03-29 | Direct | 20,500 |
Reported balance
After 2022-03-29 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-03-29 · Grant · Acquired 20,500 · Balance 20,500 F1: The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on March 29, 2023, and the remainder vesting in 12 equal quarterly installments over three years. |
Filing footnotes · ownership attribution and instrument terms
F1: The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on March 29, 2023, and the remainder vesting in 12 equal quarterly installments over three years.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Renovacor, Inc.
Report date December 01, 2022 · Filed December 06, 2022
Section 16 reporting ended · disclosed 2022-12-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-12-01 transaction · row 1
1 source rowRow 1 · 2022-12-01 · Disposition to issuer · Disposed 278,588 · Balance 0 F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of September 19, 2022, by and among the Issuer, Rocket Pharmaceuticals, Inc. ("Rocket") and the other parties thereto (the "Merger Agreement") in exchange for 49,115 shares of Rocket common stock having a market value of $18.39 per share on the effective date of the merger. |
| Stock OptionSEC Table II · derivative / convertible security · Expires 2031-09-03 | Direct | 0 |
Reported balance
After 2022-12-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-12-01 · Disposition to issuer · Disposed 24,000 · Balance 0 F2: Represents Company Options (as defined in the Merger Agreement), whether vested or unvested, that were assumed by Rocket in the merger and replaced with an option to purchase a number of Rocket common stock equal to the product of (A) the number of Issuer shares subject to such Company Option as of immediately prior to the First Effective Time (as defined in the Merger Agreement), multiplied by (B) the Exchange Ratio (as defined in the Merger Agreement), rounded down to the nearest whole number of Rocket common stock, at an exercise price per Rocket common stock underlying such option equal to the quotient obtained by dividing (x) the per share exercise price of Company Options immediately prior to the First Effective Time by (y) the Exchange Ratio, rounded up to the nearest whole cent. F3: Each Company Option described herein shall be subject to the same terms and conditions as applied to the corresponding Company Option as of immediately prior to the First Effective Time, except as otherwise provided in the Merger Agreement. |
| Stock OptionSEC Table II · derivative / convertible security · Expires 2032-05-25 | Direct | 0 |
Reported balance
After 2022-12-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-12-01 · Disposition to issuer · Disposed 12,000 · Balance 0 F2: Represents Company Options (as defined in the Merger Agreement), whether vested or unvested, that were assumed by Rocket in the merger and replaced with an option to purchase a number of Rocket common stock equal to the product of (A) the number of Issuer shares subject to such Company Option as of immediately prior to the First Effective Time (as defined in the Merger Agreement), multiplied by (B) the Exchange Ratio (as defined in the Merger Agreement), rounded down to the nearest whole number of Rocket common stock, at an exercise price per Rocket common stock underlying such option equal to the quotient obtained by dividing (x) the per share exercise price of Company Options immediately prior to the First Effective Time by (y) the Exchange Ratio, rounded up to the nearest whole cent. F3: Each Company Option described herein shall be subject to the same terms and conditions as applied to the corresponding Company Option as of immediately prior to the First Effective Time, except as otherwise provided in the Merger Agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of September 19, 2022, by and among the Issuer, Rocket Pharmaceuticals, Inc. ("Rocket") and the other parties thereto (the "Merger Agreement") in exchange for 49,115 shares of Rocket common stock having a market value of $18.39 per share on the effective date of the merger.
F2: Represents Company Options (as defined in the Merger Agreement), whether vested or unvested, that were assumed by Rocket in the merger and replaced with an option to purchase a number of Rocket common stock equal to the product of (A) the number of Issuer shares subject to such Company Option as of immediately prior to the First Effective Time (as defined in the Merger Agreement), multiplied by (B) the Exchange Ratio (as defined in the Merger Agreement), rounded down to the nearest whole number of Rocket common stock, at an exercise price per Rocket common stock underlying such option equal to the quotient obtained by dividing (x) the per share exercise price of Company Options immediately prior to the First Effective Time by (y) the Exchange Ratio, rounded up to the nearest whole cent.
F3: Each Company Option described herein shall be subject to the same terms and conditions as applied to the corresponding Company Option as of immediately prior to the First Effective Time, except as otherwise provided in the Merger Agreement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 01, 2022 Filed Dec 6, 2022 02:22 UTC | Renovacor, Inc. RCOR · Entity 114644 | Disposition to issuerStock Option · Derivative | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-023383 · form4.xml · derivative · entry 3 Amusa Gbolahan · CIK 0001761120 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,000 shares Expires 2032-05-25 F2 · derivative.exercise_price: Represents Company Options (as defined in the Merger Agreement), whether vested or unvested, that were assumed by Rocket in the merger and replaced with an option to purchase a number of Rocket common stock equal to the product of (A) the number of Issuer shares subject to such Company Option as of immediately prior to the First Effective Time (as defined in the Merger Agreement), multiplied by (B) the Exchange Ratio (as defined in the Merger Agreement), rounded down to the nearest whole number of Rocket common stock, at an exercise price per Rocket common stock underlying such option equal to the quotient obtained by dividing (x) the per share exercise price of Company Options immediately prior to the First Effective Time by (y) the Exchange Ratio, rounded up to the nearest whole cent. F3 · derivative.exercise_date: Each Company Option described herein shall be subject to the same terms and conditions as applied to the corresponding Company Option as of immediately prior to the First Effective Time, except as otherwise provided in the Merger Agreement. Read SEC document |
| December 01, 2022 Filed Dec 6, 2022 02:22 UTC | Renovacor, Inc. RCOR · Entity 114644 | Disposition to issuerStock Option · Derivative | 24,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-023383 · form4.xml · derivative · entry 2 Amusa Gbolahan · CIK 0001761120 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,000 shares Expires 2031-09-03 F2 · derivative.exercise_price: Represents Company Options (as defined in the Merger Agreement), whether vested or unvested, that were assumed by Rocket in the merger and replaced with an option to purchase a number of Rocket common stock equal to the product of (A) the number of Issuer shares subject to such Company Option as of immediately prior to the First Effective Time (as defined in the Merger Agreement), multiplied by (B) the Exchange Ratio (as defined in the Merger Agreement), rounded down to the nearest whole number of Rocket common stock, at an exercise price per Rocket common stock underlying such option equal to the quotient obtained by dividing (x) the per share exercise price of Company Options immediately prior to the First Effective Time by (y) the Exchange Ratio, rounded up to the nearest whole cent. F3 · derivative.exercise_date: Each Company Option described herein shall be subject to the same terms and conditions as applied to the corresponding Company Option as of immediately prior to the First Effective Time, except as otherwise provided in the Merger Agreement. Read SEC document |
| December 01, 2022 Filed Dec 6, 2022 02:22 UTC | Renovacor, Inc. RCOR · Entity 114644 | Disposition to issuerCommon Stock | 278,588 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-023383 · form4.xml · nonDerivative · entry 1 Amusa Gbolahan · CIK 0001761120 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Disposed of pursuant to the Agreement and Plan of Merger, dated as of September 19, 2022, by and among the Issuer, Rocket Pharmaceuticals, Inc. ("Rocket") and the other parties thereto (the "Merger Agreement") in exchange for 49,115 shares of Rocket common stock having a market value of $18.39 per share on the effective date of the merger. Read SEC document |
| May 25, 2022 Filed May 27, 2022 20:04 UTC | Renovacor, Inc. RCOR · Entity 114644 | GrantStock Option · Derivative | 12,000 | $0.00 Strike: $1.94 | $0.00 |
DisclosureSEC source: 0001062993-22-013690 · form4.xml · derivative · entry 1 Amusa Gbolahan · CIK 0001761120 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2032-05-25 F1 · derivative.exercise_date: The option vests on the earlier of (a) May 25, 2023, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| April 22, 2022 Filed Apr 26, 2022 22:48 UTC | Renovacor, Inc. RCOR · Entity 114644 | OtherCommon Stock | 78,726 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-010819 · form4.xml · nonDerivative · entry 2 Amusa Gbolahan · CIK 0001761120 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,588 F2 · kind: Represents shares of common stock distributed to the Reporting Person from Mountain Wood II LLC for no consideration. Read SEC document |
| April 22, 2022 Filed Apr 26, 2022 22:48 UTC | Renovacor, Inc. RCOR · Entity 114644 | OtherCommon Stock | 159,862 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-010819 · form4.xml · nonDerivative · entry 1 Amusa Gbolahan · CIK 0001761120 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,862 F1 · kind: Represents shares of common stock distributed to the Reporting Person from Chardan Investments 2, LLC for no consideration. Read SEC document |
| March 29, 2022 Filed Mar 31, 2022 21:21 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | GrantCommon Stock Options - Right to Buy · Derivative | 20,500 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001213900-22-016950 · ownership.xml · derivative · entry 1 Amusa Gbolahan · CIK 0001761120 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,500 Underlying: Common Stock · 20,500 shares Expires 2032-03-29 F1 · derivative.exercise_date: The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on March 29, 2023, and the remainder vesting in 12 equal quarterly installments over three years. Read SEC document |
| February 01, 2022 Filed Feb 4, 2022 01:57 UTC | Renovacor, Inc. RCOR · Entity 114644 | OtherCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-002567 · form4.xml · nonDerivative · entry 1 Amusa Gbolahan · CIK 0001761120 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 F1 · shares: Represents shares of common stock distributed to the Reporting Person from Chardan Healthcare Investments LLC for no consideration. Read SEC document |
| September 03, 2021 Filed Sep 8, 2021 23:01 UTC | Renovacor, Inc. RCOR · Entity 114644 | GrantOption · Derivative | 24,000 | $0.00 Strike: $7.73 | $0.00 |
DisclosureSEC source: 0001192482-21-000713 · edgar.xml · derivative · entry 1 Amusa Gbolahan · CIK 0001761120 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2031-09-03 F1 · derivative.exercise_date: The stock options will vest and become exercisable 25% on the first anniversary of the grant and the remainder will vest and become exercisable in 36 equal monthly installments on the 3rd of each month for the remaining 36 months, subject to the Reporting Person's continuous service as of each such date. Read SEC document |
| July 26, 2021 Filed Jul 29, 2021 01:46 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | PurchaseWarrants to purchase Common Stock · Derivative | 18,750 | Not disclosed Strike: $5.00 | Not disclosed |
DisclosureSEC source: 0001213900-21-039168 · ownership.xml · derivative · entry 2 Amusa Gbolahan · CIK 0001761120 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,750 Underlying: Common Stock · 18,750 shares Expires 2027-01-28 F1 · price: The reporting person acquired 25,000 units consisting of one share of common stock and three-quarters of one warrant at a purchase price of $4.00 per unit. Read SEC document |
| July 26, 2021 Filed Jul 29, 2021 01:46 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | PurchaseCommon Stock, par value $0.0001 | 25,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-21-039168 · ownership.xml · nonDerivative · entry 1 Amusa Gbolahan · CIK 0001761120 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,871 F1 · price: The reporting person acquired 25,000 units consisting of one share of common stock and three-quarters of one warrant at a purchase price of $4.00 per unit. Read SEC document |
| March 30, 2021 Filed Apr 1, 2021 20:20 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | GrantCommon Stock Options - Right to Buy · Derivative | 15,200 | $0.00 Strike: $7.02 | $0.00 |
DisclosureSEC source: 0001213900-21-019653 · ownership.xml · derivative · entry 1 Amusa Gbolahan · CIK 0001761120 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,200 Underlying: Common Stock · 15,200 shares Expires 2031-03-30 F1 · derivative.exercise_date: The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on March 30, 2022, and the remainder vesting in 12 equal quarterly installments over three years. Read SEC document |
| July 13, 2020 Filed Jul 27, 2020 17:37 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | OtherWarrants to purchase Common Stock · Derivative | 276,190 | Not disclosed Strike: $11.50 | Not disclosed |
DisclosureSEC source: 0001213900-20-018683 · ownership.xml · derivative · entry 2 Amusa Gbolahan · CIK 0001761120 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,190 Underlying: Common Stock · 276,190 shares Expires 2024-10-28 F1 · kind: The shares were distributed to the reporting person by Mountain Wood LLC, which distributed its securities in the issuer to its members. F1 · price: The shares were distributed to the reporting person by Mountain Wood LLC, which distributed its securities in the issuer to its members. Read SEC document |
| July 13, 2020 Filed Jul 27, 2020 17:37 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | OtherCommon Stock, par value $0.0001 | 95,148 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-20-018683 · ownership.xml · nonDerivative · entry 1 Amusa Gbolahan · CIK 0001761120 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,871 F1 · kind: The shares were distributed to the reporting person by Mountain Wood LLC, which distributed its securities in the issuer to its members. F1 · price: The shares were distributed to the reporting person by Mountain Wood LLC, which distributed its securities in the issuer to its members. Read SEC document |
| June 10, 2020 Filed Jun 13, 2020 00:33 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | OtherCommon Stock, par value $0.0001 | 142,723 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-20-014895 · ownership.xml · nonDerivative · entry 1 Amusa Gbolahan · CIK 0001761120 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,723 F1 · kind: The shares were distributed to the reporting person by Chardan Investments, LLC, which distributed its shares in the issuer to its members. F1 · price: The shares were distributed to the reporting person by Chardan Investments, LLC, which distributed its shares in the issuer to its members. Read SEC document |
| March 25, 2020 Filed Mar 27, 2020 20:05 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | GrantCommon Stock Options - Right to Buy · Derivative | 16,000 | $0.00 Strike: $6.21 | $0.00 |
DisclosureSEC source: 0001213900-20-007672 · ownership.xml · derivative · entry 1 Amusa Gbolahan · CIK 0001761120 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2030-03-25 F1 · derivative.exercise_date: The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on March 25, 2021, and the remainder vesting in 12 equal quarterly installments over three years. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.